Integra Lifesciences In Share Repurchase Agreement With Goldman Sachs

Jan 27 (Reuters) - Dr Reddy's Laboratories Ltd : * ANNOUNCES LAUNCH OF DIFLUPREDNATE OPHTHALMIC EMULSION 0.05% IN U.S. MARKET Source text for Eikon: Further company coverage:

A proposed settlement between New Jersey and the current owner of a notoriously polluted industrial site is drawing fire from residents of Toms River, where memories of children getting cancer at elevated rates are still a fresh source of pain

A newly released report from the Mississippi State Department of Health finds that an increasing number of mothers in the state have died in recent years due to pregnancy complications

Jan 26 (Reuters) - Anti-abortion protesters broke into the room where Walgreens Boots Alliance Inc held its annual shareholders meeting in Newport Coast, California on Thursday for its decision to

A group of Texas death row inmates have filed a federal lawsuit against the state’s prison system over its policy of mandatory and indefinite solitary confinement for all prisoners who are awaiting execution

Jan 26 (Reuters) - Marker Therapeutics Inc: * MARKER THERAPEUTICS INC - FILED 1-FOR-10 REVERSE STOCK SPLIT, REDUCTION IN TOTAL NUMBER OF AUTHORIZED SHARES OF COMMON STOCK TO 30 MILLION * MARKER

Jan 26 (Reuters) - Solid Biosciences Inc: * SOLID BIOSCIENCES INC FILES FOR RESALE OF UP TO ABOUT 12 MILLION SHARES OF COMMON STOCK BY SELLING STOCKHOLDERS - SEC FILING Further company coverage:

Jan 26 (Reuters) - * GENEDX ANNOUNCES PROPOSED UNDERWRITTEN PUBLIC OFFERING OF CLASS A COMMON STOCK AND CONCURRENT REGISTERED DIRECT OFFERING * GENEDX HOLDINGS CORP - EXPECTED AGGREGATE GROSS PROCEEDS

Jan 26 (Reuters) - R1 RCM Holdco Inc: * R1 RCM TO RELEASE FOURTH QUARTER 2022 RESULTS ON FEBRUARY 16 Source text for Eikon: Further company coverage:

Jan 26 (Reuters) - ContraFect Corp: * CONTRAFECT CORP - ON JAN 20, NASDAQ STAFF INFORMED CO THAT STAFF HAD DETERMINED TO DENY CO'S REQUEST FOR CONTINUED LISTING ON NASDAQ CAPITAL MARKET Further